WHO ICTRP trial
Nephrotoxicity of Iodixanol versus Iopamidol in Patients Undergoing Peripheral…
ChiCTR1800015835 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting
Key facts
| Trial ID | ChiCTR1800015835 |
|---|---|
| Public title | Nephrotoxicity of Iodixanol versus Iopamidol in Patients Undergoing Peripheral Angiography with or without Endovascular Therapy |
| Scientific title | Nephrotoxicity of Iodixanol versus Iopamidol in Patients Undergoing Peripheral Angiography with or without Endovascular Therapy |
| Primary sponsor | Dept. of Cardiology, Fuwai Hospital, Chinese academy of Medical Sciences and Peking Union Medical College |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional study |
| Phase | Post-market |
| Countries | China |
| Conditions | Peripheral vascular disease |
| Interventions | iodixanol group:iodixanol;iopamidol group:iopamidol |
| Registration date | Apr 24, 2018 |
| Target size | iodixanol group:444;iopamidol group:444 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: